Flagship Harbor Advisors, LLC Haemonetics Corp Transaction History

Flagship Harbor Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$88.75 - $119.95 $2,218 - $2,998	-25 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$75.65 - $93.58 $7,565 - $9,358	-100 Reduced 80.0%	25 $2,000
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $11,437 - $12,946	100 Added 400.0%	125 $14,000
Q1 2019 Apr 15, 2019	SELL	$83.25 - $102.12 $4,578 - $5,616	-55 Reduced 68.75%	25 $2,000
Q3 2018 Nov 05, 2018	BUY	$89.96 - $114.58 $2,249 - $2,864	25 Added 45.45%	80 $9,000
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $3,934 - $5,266	55 New	55 $4,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.93B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.